EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Chasing Shadows? Antibiotic Treatment for Asymptomatic Bacteriuria in the First 30 Days Post Kidney Transplant

Ralph Tayyar, Michaela Johnson Blachard, Kristine Lan, Carlos Gabiel D Corpuz, Jennifer Hu, Amal Hamdan, Robert M Rakita, Anna Wald, Cynthia E Fisher

Open Forum Infectious Diseases · 16.11.2026

DOI: 10.1093/ofid/ofag750 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Open Forum Infectious Diseases, online erschienen am 16.11.2026. Verfasst von Ralph Tayyar und 8 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Asymptomatic bacteriuria (ASB) is common after kidney transplantation, but the benefit of antibiotic treatment immediately after transplant remains uncertain. We evaluated whether ASB treatment within 30 days was associated with improved rejection, allograft function, and infectious outcomes.

Methods

We retrospectively studied of adult kidney transplant recipients at the University of Washington (January 2017-April 2025) who developed ASB within 30 days of transplantation. The primary outcome was biopsy-proven rejection within 1 year by ASB treatment. Secondary outcomes included UTI within 2 weeks after ASB, multidrug-resistant organism (MDRO) isolation, Clostridioides difficile infection (CDI) within 1 year, and eGFR at 1-month and 1-year after transplant. Multivariate Cox, logistic and linear regression models were used, with propensity score and inverse probability of treatment weighting (IPTW) sensitivity analyses.

Results

Among 1,851 kidney transplant recipients, 359 developed ASB episodes within 30 days, comprising 620 episodes. Seventy-two patients (112 episodes) received antibiotics and 287 (508 episodes) did not. Propensity-adjusted and IPTW analyses did not show increased rejection risk in untreated patients, HR, 1.26 [95% CI, 0.44–3.56] and HR, 1.03 [95% CI, 0.34–3.19], respectively. Treatment was associated with higher odds of UTI within 2 weeks after ASB, adjusted OR, 6.5 [95% CI, 1.5–33.4]. MDRO isolation, CDI, and eGFR at 1-month and 1-year were not different between treated and untreated patients.

Conclusion

No differences in rejection or allograft function at one year post kidney transplant were detected between patients with treated and untreated ASB but treatment had higher occurrence of UTI within two weeks after detection of ASB.

Zitieren

APA

Tayyar, R., Blachard, M. J., Lan, K., Corpuz, C. G. D., Hu, J., Hamdan, A., Rakita, R. M., Wald, A., & Fisher, C. E. (2026). Chasing Shadows? Antibiotic Treatment for Asymptomatic Bacteriuria in the First 30 Days Post Kidney Transplant. Open Forum Infectious Diseases. https://doi.org/10.1093/ofid/ofag750

Vancouver

Tayyar R, Blachard MJ, Lan K, Corpuz CGD, Hu J, Hamdan A, et al. Chasing Shadows? Antibiotic Treatment for Asymptomatic Bacteriuria in the First 30 Days Post Kidney Transplant. Open Forum Infectious Diseases. 2026. doi:10.1093/ofid/ofag750

BibTeX
@article{Tayyar2026,
  author = {Tayyar, Ralph and Blachard, Michaela Johnson and Lan, Kristine and Corpuz, Carlos Gabiel D and Hu, Jennifer and Hamdan, Amal and Rakita, Robert M and Wald, Anna and Fisher, Cynthia E},
  title = {Chasing Shadows? Antibiotic Treatment for Asymptomatic Bacteriuria in the First 30 Days Post Kidney Transplant},
  journal = {Open Forum Infectious Diseases},
  year = {2026},
  doi = {10.1093/ofid/ofag750}
}
Kostenlos starten →